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Early infant HIV diagnosis (EID) is critical to ensuring timely diagnosis of HIV-exposed
infants, and treatment in those found to be infected. However estimates of coverage vary
considerably, depending on data sources used. We used 4 methods to estimate coverage
among a historical cohort of HIV-exposed infants in rural South Africa, between 2010–2016.
Methods
We estimated the proportion of infants ever tested (methods 1–3) and tested by 7 weeks of
age (1–4) as follows: (1) infants born to women identified as HIV-positive in demographic
surveillance were linked to those with�1 EID result in routine laboratory surveillance; (2)
the number of infants with�1 EID result in laboratory surveillance divided by the estimated
number of HIV-exposed infants, calculated as total live births multiplied by antenatal HIV
seroprevalence; (3) the number of infants with�1 EID result in routine laboratory surveil-
lance, divided by the number of HIV-exposed infants as estimated by the district health ser-
vice; (4) from documentation in infants’ Road-to-Health-booklets.
Results
The proportion ever tested was 43%, 88% and 138% for methods 1–3, and by 7 weeks of
age was 25%, 49%, 86% and 46% for methods 1–4 respectively.
PLOS ONE







Citation: Chappell E, Thorne C, Collins IJ, Baisley K,
Yapa HM, Gareta D, et al. (2021) It ain’t what you
do, it’s the way that you do it: The pitfalls of using
routine data to measure early infant HIV diagnosis
in HIV-exposed infants. PLoS ONE 16(9):
e0257496. https://doi.org/10.1371/journal.
pone.0257496
Editor: Emma K. Kalk, University of Cape Town,
SOUTH AFRICA
Received: March 29, 2021
Accepted: September 2, 2021
Published: September 30, 2021
Copyright: © 2021 Chappell et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: The data underlying
this analysis are available at: https://doi.org/10.
23664/Comparing.estimates.of.testing.coverage.
Funding: This work was supported by a Medical
Research Council studentship (programme
number MC_UU_12023) to EC. The Africa Health
Research Institute (previously Africa Centre for
Population Health, University of KwaZulu-Natal,
South Africa) receives core funding from the
Wellcome Trust, which provides the platform for
Conclusions
The four methods, applied to a range of routine data sources, resulted in estimates varying
considerably, and the true coverage of EID remains unclear. Our findings highlight the
importance of developing unique patient identifiers, improving training of healthcare provid-
ers using reporting systems, and ensuring the accuracy of healthcare records, to ensure the
best possible health outcomes for HIV-exposed infants.
Introduction
Since the launch of the prevention of mother-to-child transmission (PMTCT) program in
South Africa in 2004, the rate of vertical transmission of Human Immunodeficiency Virus
(HIV) in South Africa has fallen from 31.2% to 4.8% in 2017 [1]. Nonetheless, with a high ante-
natal HIV seroprevalence of>40% in some regions, a substantial number of infants are still
born with HIV [2]. There is high early mortality in this group [3], making timely testing and
diagnosis of these infants to enable linkage to care and treatment important, and the propor-
tion of HIV-exposed infants who actually receive a PCR test a critical indicator of health sys-
tems performance.
Since 2004, South African national guidelines have recommended that all HIV-exposed
infants receive early infant HIV diagnosis (EID) using deoxyribonucleic acid (DNA) polymer-
ase chain reaction (PCR) tests by 6 weeks of age. These guidelines were updated in April 2015
to recommend a PCR test at birth, with a subsequent PCR test for confirmation for those test-
ing positive, or a repeat test for those testing negative at 10–18 weeks of age [4]. Additional
testing of symptomatic infants and at 6 weeks after the cessation of breastfeeding has been rec-
ommended throughout.
Previous estimates of the proportion of infants tested by 2 months of age in South Africa
between 2010 and 2016 have ranged from 52% to over 100% [5–8]. Sources of data used by
studies include patient records, national laboratory service data, aggregated reports from
healthcare facilities and interview with caregivers. One study comparing national estimates
from two sources of routinely collected data found substantial variation both between the two
methods, as well as with each method when alternative definitions of the denominator of HIV-
exposed infants (based either directly on the reported number of HIV-exposed infants, or on
the total number of infants multiplied by the estimate antenatal HIV seroprevalence) were
used [6]. The reasons for this variation and limitations of the sources of routinely collected
data used are not always well investigated.
Given the importance of accurately estimating coverage in ensuring optimal care for this
vulnerable population, we compare four different methods, using different sources of data, for
estimating coverage among a historical cohort of infants born between 1st June 2010 and 31st
December 2016 in the Hlabisa health sub-district, KwaZulu-Natal. We discuss the strengths,
weaknesses and potential biases for each method, and make recommendations for improved
monitoring.
Materials and methods
The Hlabisa health sub-district lies within the uMkhanyakude district, KwaZulu-Natal, South
Africa. It is a predominantly rural area, with a population of 228,000 people [9]. In 2016, the
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HIV prevalence was estimated at 48% among women attending antenatal care [10]. The sub-
district contains 16 primary healthcare clinics and one hospital.
Since 2000, the Africa Health Research Institute (AHRI) has conducted demographic
surveillance in part of the sub-district, which covers a population of 85,000 people [11].
Households and individuals are followed longitudinally, and dried blood spots for HIV
surveillance are collected on resident adults aged �15 years [9]. Overall participation has
been estimated at >99% [11], with 77% of adults estimated to have participated in the
HIV surveillance component at least once in the first 9 years of becoming resident [12].
Participating individuals are linked to records in Three Integrated Electronic Register
(TIER).net, the national Department of Health antiretroviral therapy (ART) monitoring
system, from the 17 healthcare facilities in the sub-district, using a deterministic and
probabilistic algorithm based on South African national ID number, name, cell phone
number, date of birth, sex and nearest clinic.
The National Health Laboratory Service (NHLS) is responsible for laboratory testing
in public facilities in South Africa. Data on all HIV DNA PCR tests conducted (regard-
less of the age of the individual) between 1st June 2010 and 1st July 2017 were down-
loaded from the NHLS database through a secure file transfer protocol. A second
deterministic and probabilistic data linkage algorithm, based on first name, surname,
sex, date of birth, facility at which the test was conducted and the infant’s facility ID was
used to identify repeat tests on the same child. Although South African national ID num-
ber is a field on the test request forms, it was completed for <1% of PCR tests (among
which no two records had the same ID number recorded), and so was not used for link-
age. To assess the accuracy of this algorithm the proportion of individuals in the result-
ing deduplicated dataset who had the same surname, date of birth and sex as another
individual was compared to the same proportion in a dataset of known unique individu-
als from the AHRI surveillance area.
The four methods used to estimate testing coverage are described below and in Table 1.
Table 1. Summary of the four methods used to estimate PCR testing coverage.
Method 1: NHLS-AHRI
surveillance




who received a PCR test)
Infants with a linked NHLS
PCR test
Number of infants with a PCR test in the
NHLS database
Number of infants with a
PCR test in the NHLS
database
Infants with a PCR test recorded
in their Road-to-Health booklet




Infants born to women
testing positive in serosurvey
or initiating ART in TIER.
net database
Number of live births from SSA (adjusted
for late registrations) multiplied by
antenatal HIV seroprevalence from
ANCHSS (adjusted for incident HIV
between sampling and delivery)
Aggregated returns of
number of live births to
HIV-positive women sent
from clinics to DHIS
Infants born to HIV-positive
women attending antenatal care




Yes No No Yes
Geographical area
covered
AHRI surveillance area Hlabisa health sub-district Hlabisa health sub-district AHRI surveillance area
Calendar time period
covered (infant’s date of
birth)
June 2010 to December 2016 June 2010 to December 2016 April 2014 to December
2016
July 2015 to December 2016
AHRI: Africa Health Research Institute; ANCHSS: National Antenatal Sentinel HIV and Syphilis Survey Report; DHIS: District Health Information System; HIV:
Human Immunodeficiency Virus; MONARCH: Management and Optimization of Nutrition, Antenatal, Reproductive, Child Health and HIV Care; NHLS: National
Health Laboratory Service; PCR: Polymerase Chain Reaction; SSA: Statistics South Africa.
https://doi.org/10.1371/journal.pone.0257496.t001
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Method 1: NHLS-AHRI surveillance
Infants born in the AHRI surveillance area whose mothers were identified as HIV-positive
through participation in HIV surveillance and/or linkage to TIER.net were the denominator.
A third deterministic and probabilistic linkage algorithm between these infants and the NHLS
database (based on infant’s first name, surname, date of birth and sex) was used to estimate the
proportion tested.
Method 2: NHLS-Statistics South Africa (SSA)/National Antenatal Sentinel
HIV and Syphilis Survey Report (ANCHSS)
Testing coverage was estimated using the number of infants tested in the NHLS database,
divided by the number of HIV-exposed infants born in the sub-district, which was calculated
for each year of birth using SSA estimates of the number of live births multiplied by ANCHSS
estimates of the antenatal HIV seroprevalence.
SSA publishes the number of live births annually, using data on birth registrations [13–19],
however late registration of some births means that reported estimates for each year of birth
increase over time. We used the average increase in reported estimates in previous years to
adjust estimates for more recent calendar years to reflect this (see S1 Table). Figures are pub-
lished on a district level, so were scaled for the sub-district using the size of the population of
the Hlabisa sub-district and the uMkhanyakude district (228,000/625,000 = 36.5%) [9,20].
Estimates of antenatal seroprevalence were based on those from the annual ANCHSS sur-
vey [21], for which consenting women attending antenatal care at a sample of public healthcare
facilities across South Africa receive an HIV antibody test. We adjusted estimates to account
for HIV infections acquired between sampling for the survey and delivery which would not
have been captured, with the rate of incident HIV during pregnancy in the sub-district esti-
mated at 4.5 per 100-person-years [22]. Between 2010 and 2014 only women at their first ante-
natal clinic visit were included in the ANCHSS survey, which occurs at a median gestational
age of 19.5 weeks in the sub-district (estimated using data from MONARCH, see below).
From 2015, ANCHSS methods were updated to remove this restriction, resulting in an esti-
mated median gestational age of 37.5 weeks at sampling.
For comparison, testing coverage based on unadjusted estimates of the number of live
births and antenatal seroprevalence, and PCR test data prior to deduplication of repeat tests,
was also calculated.
Method 3: NHLS-District Health Information System (DHIS)
For this method, the coverage estimate was derived from the number of infants tested (NHLS
data), divided by an estimate of the number of HIV-exposed infants born in the sub-district
from DHIS data. All public health facilities in South Africa send aggregated data on their activ-
ity to DHIS, including the number of live births to women with HIV. These estimates were
adjusted to account for infants not born in healthcare facilities, estimated through AHRI sur-
veillance to be 3% of all births. DHIS data were only available from April 2014 onwards.
Method 4: Road-to-Health booklets
This method used routinely collected data which was accessed through MONARCH, a trial
which evaluated the impact of a quality improvement intervention package on PMTCT pro-
cesses [23,24]. All children in South Africa are given a patient-held medical record at birth,
called the Road-to-Health Booklet, in which information including HIV testing is recorded.
As part of the trial, booklets belonging to all infants born to women receiving antenatal care at
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the 7 clinics in the AHRI surveillance area between July 2015 and December 2016 were photo-
graphed up to the 6-week postnatal visit. By 6 weeks of age only 25% of infants in MONARCH
had had their 6-week postnatal visit, compared to 90% by 7 weeks of age. Testing coverage was
estimated as the proportion of HIV-exposed infants with a PCR test recorded. MONARCH
was conducted after the change to testing guidelines, so all infants would be expected to be
tested at birth, but a sensitivity analysis was conducted to compare coverage among infants
whose booklet was photographed at their 6-week visit to that in infants whose booklet was
only seen earlier using a chi-squared test with Rao-Scott correction to account for clustering
by clinic.
Estimation of testing coverage
As data on PCR testing were only available to the 6-week postnatal visit for MONARCH, esti-
mates of the overall testing coverage (proportion of infants ever tested) were compared across
methods 1–3 only, and estimates of testing coverage by 7 weeks of age were compared across
all four methods. Coverage was estimated by year of birth, and separately before and after the
introduction of birth testing in the national guidelines (<1st April 2015 vs.�1st April 2015).
Ethical approval
Ethical approval for: (i) the demographic surveillance, linkage to TIER.net, NHLS and other
routine data sources, and analyses of these data; and (ii) the MONARCH trial; were granted by
the University of KwaZulu-Natal Biomedical Research Ethics Committee (references BE290/
16 and BE209/14 respectively). A waiver of the requirement for individual level informed con-
sent was awarded, given the use of routine Department of Health data. Directly identifiable
variables were required for the purposes of data linkage and were accessed in an on-premise
secure environment.
Results
The estimates of testing coverage in infants born to women living with HIV from each of the
four methods are shown in Table 2 and Fig 1. Details of the calculations for each method are
shown in S1–S5 Tables.
In total, 17,622 PCR tests were extracted from the NHLS database, and following deduplica-
tion of those with repeat tests, 15,234 unique infants were identified. The proportion of these
infants who had the same surname, date of birth and sex as another infant was 5.7%, compared
to 4% in a dataset of known unique individuals.
For method 1, 2,254 HIV-exposed infants were identified, of whom 965 were linked to a
PCR test in the NHLS database, giving an overall testing coverage of 43%. By year, this
increased from 38% in 2010 to 48% in 2012 and 2013, before falling again to 29% in 2016.
With method 2, the total number of HIV-exposed infants born within the sub-district was
estimated at 17,570, giving a resulting overall testing coverage estimate across the whole time
period of 87% (15,234/17,570). By year of birth, estimates ranged from 75% to 99%, with no
clear trend over time. The use of unadjusted estimates in the calculation of the number of
HIV-exposed infants and of PCR test data prior to deduplication resulted in an increase in the
estimate of testing coverage over the whole time period from 88% to 109%.
Using method 3, the number of infants born within the sub-district from April 2014 was
estimated to be 5,115, with the corresponding number of infants tested being higher at 7,063.
Testing coverage for this time period therefore impossibly exceeded 100%, at 138%, ranging
from 101% to 160% by year of birth.
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Comparing estimates of coverage to 7 weeks of age across methods 1–3, the same pattern
was observed as for overall coverage, with the lowest estimate coming from method 1 and the
highest from method 3. For method 4, 813 infants included in the MONARCH trial had avail-
able data recorded from their Road-to-Health booklet, of whom 290 (35%) had their booklet
photographed at their 6-week visit compared to 547 (65%) whose booklet was only seen at ear-
lier visits. In total, 378 had a PCR test recorded, giving an estimate of testing coverage to 7
weeks of age of 46%, somewhere in the middle of those made with the other methods. There
was evidence that the proportion of infants with PCR test data recorded was higher among
those seen at 6 weeks compared to those not (147/290 (51%) vs. 231/523 (44%), p = 0.039).
Discussion
In this analysis we have explored the use of different methods and sources of routinely col-
lected data in estimating the proportion of HIV-exposed infants in a rural South African set-
ting with high antenatal HIV prevalence who received a PCR test. There was high variation in
the estimates from each method.




































































































































































Data only available from April 2014 onwards for Method 3 and from July 2015 onwards for Method 4. AHRI: Africa Health Research Institute; ANCHSS: National
Antenatal Sentinel HIV and Syphilis Survey Report; DHIS: District Health Information System; NHLS: National Health Laboratory Service; SSA: Statistics South Africa.
Confidence intervals are not presented where the estimated proportion exceeds 100%.
https://doi.org/10.1371/journal.pone.0257496.t002
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A summary of the limitations of each method is shown in Table 3. Methods 1 to 3 relied on
accurate linkage of repeat tests on the same infant within NHLS. It is known that an infant’s
mother’s name may be used on the laboratory test request form instead of the infant’s for tests
conducted in early life (as their name may not yet have been chosen), which makes linkage to
subsequent tests difficult. The lack of a unique identifier also made deterministic linkage diffi-
cult. Although South African national ID is often missing on NHLS forms in general, record-
ing is particularly poor for test requests for infants; ID numbers are only allocated at civil
registration of birth, and so many infants don’t have a number at the time of testing. The pro-
portion of infants in our final ‘deduplicated’ dataset who had the same surname, date of birth
and sex was slightly higher than observed in another dataset of known unique individuals, sug-
gesting a small amount of underlinkage. Underlinkage of repeat tests would have resulted in
Fig 1. Comparison of estimates of coverage, both (a) overall, and (b) to 7 weeks of age. Data only available from April
2014 onwards for Method 3 and from July 2015 onwards for Method 4. Method 1 = NHLS-AHRI surveillance, Method
2 = NHLS-SSA/ANCHSS, Method 3 = NHLS-DHIS, Method 4 = Road-to-Health booklets (MONARCH). AHRI:
Africa Health Research Institute; ANCHSS: National Antenatal Sentinel HIV and Syphilis Survey Report; DHIS:
District Health Information System; NHLS: National Health Laboratory Service; SSA: Statistics South Africa.
https://doi.org/10.1371/journal.pone.0257496.g001
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overestimation of the total number of unique infants tested, and thus overestimation of cover-
age. Conversely, limitations of the available identifiers may have also resulted in missed links
between demographic surveillance and NHLS data in method 1, leading to underestimation of
testing coverage; this may explain why estimates based on method 1 were lower than those for
the other methods. Another limitation of method 1 is that only women who agreed to partici-
pate in HIV surveillance or were on treatment would be identified. Poor maternal adherence
to treatment is known to be associated with poor uptake of EID services [25], so testing cover-
age among the infants of women not captured here may be lower.
For method 2, based on data from SSA and the ANCHSS, accurately estimating the number
of HIV-exposed infants was difficult. Reported seroprevalence from ANCHSS varied substan-
tially by year, for example from 41% to 35% to 44% in 2011, 2012 and 2013 respectively, result-
ing in corresponding variation in testing coverage estimates over time. This variation is likely
Table 3. Limitations of the methods and the likely direction of bias on the estimate of coverage.









1, 2, 3 NHLS PCR dataset NHLS data limitations, including use of
mother’s name instead of infant’s and
lack of unique identifier, may have led to





Failure to link infants to their PCR tests Misclassification Underestimation
4 Recording of PCR
tests in Road-to-
Health booklets
Known poor completion of PCR data in
Road-to-health booklet
Misclassification Underestimation
Not all infants had their Road-to-health






1 Women in AHRI
surveillance known
to have HIV
Only women on ART or willing to
participate in serosurvey can be included
Selection bias Either
Small number of women included Reliability Either
2 SSA/ANCHSS Seroprevalence estimate based on small
number of survey participants in each
district
Reliability Either
Women acquiring HIV after sampling
for survey not included
Misclassification Overestimation Estimate of incident HIV
during pregnancy used to
adjust seroprevalence
Underestimation of number births due
to late registration
Misclassification Overestimation Change in reported
numbers over time used
to adjust estimates for
more recent years
Numerator not directly linked to
denominator
Validity Either
3 DHIS Known underreporting of births in
DHIS data
Misclassification Overestimation
Infants born outside of healthcare
facility not included
Misclassification Overestimation Numbers adjusted for
infants born at home
Numerator not directly linked to
denominator
Validity Either
AHRI: Africa Health Research Institute; ANCHSS: National Antenatal Sentinel HIV and Syphilis Survey Report; DHIS: District Health Information System; HIV:
Human Immunodeficiency Virus; MONARCH: Management and Optimization of Nutrition, Antenatal, Reproductive, Child Health and HIV Care; NHLS: National
Health Laboratory Service; PCR: Polymerase Chain Reaction; SSA: Statistics South Africa.
https://doi.org/10.1371/journal.pone.0257496.t003
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due to small numbers sampled in each district, for example only 361 women from 20 clinics in
uMkhanyakude in 2015 [21]. Similarly, it was unclear whether we fully accounted for late reg-
istrations of births; adjustments were made using known underreporting by 5 years of age,
though completeness of birth registration in South Africa was only estimated at 90% by this
age for those born in 2008 [26].
Estimates made using data from DHIS (method 3) were clearly incorrect as they exceeded
100% for all calendar years. This suggests significant underestimation of the total number of
HIV-exposed infants born in the sub-district, with reported numbers being less than half of
those calculated in method 2. DHIS does have data quality assessment processes, but other
studies have reported unreliable data collection, with errors arising from poorly designed data
collection tools, incorrect transcription of values, and staff not knowing the definition of all
data items required [6,27].
Method 4 estimates, based on Road-to-Health booklets, were lower than those from meth-
ods 3, and similar to those from method 2. A cross-sectional study in Pretoria, South Africa in
2012 found that only 67% of HIV-exposed infants had the 6 week PCR test recorded in their
booklet, and that 24% had no record of maternal HIV status [28]. It is known that parents
often request HIV-related data be omitted from booklets or remove relevant pages themselves,
to protect confidentiality if the booklet is seen by other family members or school staff, and
therefore may not reflect actual EID access [29]. It is possible that recording of information in
Road-to-Health booklets may have been more complete than normal here, given that facilities
knew data were being used for a research study.
Given the limitations to each of the methods described above, apart from method 3 which
produced estimates over 100% for some time period and thus may be considered the least reli-
able, it is unclear which method should be considered most accurate. The use of aggregated or
population-level data impacts validity, as different infants may be included in the numerator
and denominator, and thus the use of individual-level data with methods 1 and 4 may there-
fore be preferable. It should however be noted that the use of widely available and routinely
collected data for methods 2 and 3 enables quicker and easier analysis, which may be more eas-
ily scaled up to estimate coverage in a larger population.
Three other South African studies have used approaches similar to method 2 to estimate
EID coverage, however none deduplicated infants with repeat tests in the NHLS data or made
adjustments to the number of live births and antenatal seroprevalence. Estimates from these
studies ranged from 52–94% [5,6,27], and were higher than the adjusted estimates reported
here (but closer to the unadjusted estimates presented in the supplementary tables), demon-
strating overestimation caused by inability to account for limitations of data. Other South Afri-
can studies assessing EID coverage have used electronic health records from single hospitals,
where identification of HIV-exposed infants and of repeat tests is likely to have been a simpler
process than in our study across healthcare clinics. Kalk et al looked at coverage at a healthcare
facility in the Western Cape between February 2014 and June 2016, with 89% of HIV-exposed
infants ever reported to have received a PCR test [7]. Smith et al estimated EID coverage at a
hospital in uMkhanyakude outside of Hlabisa sub-district to be 54% in 2012 [30]. Finally,
UNAIDS modelled estimates of EID coverage in South Africa were higher than those here, but
varied substantially year-on-year, for example from 114% in 2015 to 79% in 2016 to 101% in
2017, further highlighting the methodological difficulties in estimating this indicator [31].
Our findings lead to several recommendations for improvements to policy and practice,
which may have a public health benefit beyond EID. Firstly, the more widespread use of a
unique patient identifier should be encouraged to enable accurate identification of repeat tests
on the same infant and linkage to other data sources. Earlier assignment of the national ID
number or the use of a number specific to the laboratory service should be considered. This
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would also facilitate tracing and follow-up of infants who move clinics after diagnosis. The
national implementation of the Health Patient Registration System (HPRS) is working to
improve use of ID numbers in South Africa [32]. Secondly, reasons for the current poor com-
pletion of DHIS tools need to be better understood, and suitable training and support proce-
dures identified, with the importance of their use as a tool for monitoring healthcare systems
emphasised. Thirdly, alternative ways of maintaining accurate and complete records of patient
data while mitigating concerns about privacy violations should be explored, for example, using
codes in Road-to-Health booklets to record HIV-related information [28].
Despite access to multiple sources of data, and application of a variety of methods, the true
level of PCR testing coverage in the Hlabisa health sub-district cannot be confidently esti-
mated. It is critical to ensure that infants at risk of HIV are appropriately followed and tested
after birth, to eliminate the risk of infections remaining undiagnosed and enable early initia-
tion of ART. While the use of routine data from sources such as those used here is increasing,
both in South Africa and across other settings, few studies have explored their limitations or
the impact of these limitations on results in this detail. There are limitations to all sources of
routinely collected data, which should be considered when interpreting estimates, as well as
for informing future improvements to data collection systems and processes. Improved
recording of test data in the Road-to-Health booklets and laboratory forms, along with more
widespread use of a unique patient identifier, is required, both for quality and continuity of
clinical care to ensure the best possible outcomes, and surveillance and research purposes.
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